End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.084 AUD | -1.18% | +3.70% | +42.37% |
Jun. 03 | Percheron Therapeutics Names Chief Medical Advisor | MT |
May. 29 | Percheron Therapeutics Completes Enrollment for Phase Two Muscular Dystrophy Trial; Shares Rise 3% | MT |
Chart calendar Percheron Therapeutics Limited
Upcoming events on Percheron Therapeutics Limited
Past events on Percheron Therapeutics Limited
2024-06-02 | Bio International Convention |
2024-04-29 06:53 pm | March 2024 Sales and Revenue Release - Activities Report |
2024-03-02 | Muscular Dystrophy Association Clinical and Scientific Conference - Poster No - V410 |
2024-03-02 | Muscular Dystrophy Association Clinical and Scientific Conference - Poster No - V409 |
2024-03-02 | Muscular Dystrophy Association Clinical and Scientific Conference - Poster No - M149 |
2024-02-28 01:20 am | Q2 2024 Earnings Release |
2024-01-30 05:12 pm | December 2023 Sales and Revenue Release - Activities Report |
2024-01-07 | JPMorgan Healthcare Conference |
2024-01-07 | Biotech Showcase |
2023-11-14 10:00 pm | Annual General Meeting |
2023-10-31 | AusBiotech Conference |
2023-10-30 06:38 pm | September 2023 Sales and Revenue Release - Activities Report |
2023-10-17 04:45 pm | BIO Investor Forum |
2023-09-08 12:00 am | ShareCafe Small Cap Hidden Gems Conference |
2023-08-25 04:08 am | Q4 2023 Earnings Release |
2023-07-27 07:37 pm | June 2023 Sales and Revenue Release - Activities Report |
2023-04-16 07:38 pm | March 2023 Sales and Revenue Release - Activities Report |
2023-02-22 12:24 am | Interim 2023 Earnings Release |
2023-01-24 | December 2022 Sales and Revenue Release - Activities Report |
2022-11-16 10:00 pm | Annual General Meeting |
Annual results
Fiscal Period | June | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million AUD | Released Forecast Spread | 0,77 | 0,64 6,30 -89.89% | 1,81 1,40 29.41% | 1,96 1,80 9.15% | 3,60 |
EBITDA Million AUD | Released Forecast Spread | 0,00 | -7,95 -8,88 10.49% | -5,71 -11,3 49.31% | -11,3 -12,1 7.07% | -13,2 |
EBIT Million AUD | Released Forecast Spread | 0,00 | -8,05 -8,87 9.28% | -5,80 -11,3 48.6% | -11,4 -12,2 6.66% | -13,3 |
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | 0,00 | -8,06 -8,20 1.7% | 0,00 0,00 - | -11,4 -8,80 -29.32% | -17,2 |
Net income Million AUD | Released Forecast Spread | 0,00 | -8,06 -8,96 10.02% | 0,00 0,00 - | -11,4 -11,9 4.72% | -13,1 |
EPS AUD | Released Forecast Spread | 0,00 | -0,01 -0,02 6.88% | 0,00 0,00 - | -0,02 -0,02 4.39% | -0,02 |
Announcement Date | 26/08/20 | 25/08/21 | 31/08/22 | 25/08/23 | - |
Quarterly results
Fiscal Period | June | 2021 S2 | 2024 S1 |
---|---|---|---|
Net sales Million AUD | Released Forecast Spread | 1,20 0,00 - | |
EBITDA Million AUD | Released Forecast Spread | -6,01 -6,00 -0.17% | -4,69 -8,50 44.78% |
EBIT Million AUD | Released Forecast Spread | -6,01 -6,00 -0.17% | -4,74 -8,50 44.23% |
Net income Million AUD | Released Forecast Spread | -4,74 -8,60 44.85% | |
EPS AUD | Released Forecast Spread | -0,01 -0,01 40% | |
Announcement Date | 25/08/21 | 28/02/24 |
Past sector events for Percheron Therapeutics Limited
2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PER Stock
- Calendar Percheron Therapeutics Limited